Kulicke & Soffa Industries Inc: Form 10-K/A for the period ended Oct 1, 2022
Filed with the SEC on Aug 8, 2023 and accepted by EDGAR at Aug 8, 2023, 20:14 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-10-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2021-10-03 to 2022-10-01 | $1.50bn | us-gaap:Revenues |
| Cost of revenue | 12 months2021-10-03 to 2022-10-01 | $755.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2021-10-03 to 2022-10-01 | $748.3m | us-gaap:GrossProfit |
| Research and development | 12 months2021-10-03 to 2022-10-01 | $136.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2021-10-03 to 2022-10-01 | $141.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2021-10-03 to 2022-10-01 | $470.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2021-10-03 to 2022-10-01 | $208.0k | us-gaap:InterestExpense |
| Income tax | 12 months2021-10-03 to 2022-10-01 | $43.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2021-10-03 to 2022-10-01 | $433.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2021-10-03 to 2022-10-01 | $7.09 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2021-10-03 to 2022-10-01 | $7.21 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2021-10-03 to 2022-10-01 | 61,182,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2021-10-03 to 2022-10-01 | $390.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2021-10-03 to 2022-10-01 | $23.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2021-10-03 to 2022-10-01 | $39.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2021-10-03 to 2022-10-01 | $281.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-10-01 | $555.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-10-01 | $1.33bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-10-01 | $1.59bn | us-gaap:Assets |
| Current liabilities | At period end2022-10-01 | $248.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-10-01 | $393.9m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-10-01 | $1.19bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000056978-23-000103. Last ingested by Listed: Oct 24, 2026, 14:53 ET. Listed shows no prices and gives no investment advice.